These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9384944)

  • 1. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related?
    Wilens TE; Spencer TJ; Biederman J
    Harv Rev Psychiatry; 1995; 3(3):160-2. PubMed ID: 9384944
    [No Abstract]   [Full Text] [Related]  

  • 2. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders.
    Wilens TE; Biederman J; Spencer TJ; Frances RJ
    Hosp Community Psychiatry; 1994 May; 45(5):421-3, 435. PubMed ID: 8045536
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.
    Biederman J; Wilens T; Mick E; Milberger S; Spencer TJ; Faraone SV
    Am J Psychiatry; 1995 Nov; 152(11):1652-8. PubMed ID: 7485630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples.
    Biederman J; Faraone SV; Keenan K; Benjamin J; Krifcher B; Moore C; Sprich-Buckminster S; Ugaglia K; Jellinek MS; Steingard R
    Arch Gen Psychiatry; 1992 Sep; 49(9):728-38. PubMed ID: 1514878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ADHD in adult substance abusers.
    Moura HF; Faller S; Benzano D; Szobot C; von Diemen L; Stolf AR; Souza-Formigoni ML; Cruz MS; Brasiliano S; Pechansky F; Kessler FH
    J Addict Dis; 2013; 32(3):252-62. PubMed ID: 24074191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
    Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse.
    Horner BR; Scheibe KE
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD Medication and Substance-Related Problems.
    Quinn PD; Chang Z; Hur K; Gibbons RD; Lahey BB; Rickert ME; Sjölander A; Lichtenstein P; Larsson H; D'Onofrio BM
    Am J Psychiatry; 2017 Sep; 174(9):877-885. PubMed ID: 28659039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.
    Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR
    Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial transmission of ADHD and psychoactive substance use disorders.
    Adler LA
    Am J Psychiatry; 2008 Jan; 165(1):11-2. PubMed ID: 18178750
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of substance abuse.
    Kaul P; Coupey SM
    Pediatr Rev; 2002 Mar; 23(3):85-94. PubMed ID: 11875181
    [No Abstract]   [Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
    Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
    Barzman DH; Fieler L; Sallee FR
    J Leg Med; 2004 Mar; 25(1):23-38. PubMed ID: 15208788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.